A detailed history of Hara Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hara Capital LLC holds 10,661 shares of BMY stock, worth $618,338. This represents 0.34% of its overall portfolio holdings.

Number of Shares
10,661
Previous 11,356 6.12%
Holding current value
$618,338
Previous $472 Million 16.96%
% of portfolio
0.34%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$39.66 - $51.75 $27,563 - $35,966
-695 Reduced 6.12%
10,661 $552 Million
Q2 2024

Jul 29, 2024

SELL
$40.25 - $52.99 $1,046 - $1,377
-26 Reduced 0.23%
11,356 $472 Million
Q1 2024

Apr 26, 2024

SELL
$47.98 - $54.4 $6,957 - $7,888
-145 Reduced 1.26%
11,382 $617 Million
Q4 2023

Feb 06, 2024

BUY
$48.48 - $57.85 $558,828 - $666,836
11,527 New
11,527 $591 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Hara Capital LLC Portfolio

Follow Hara Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hara Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hara Capital LLC with notifications on news.